Johnson & Johnson (JNJ) Social Stream



Johnson & Johnson (JNJ): $154.29

0.86 (-0.55%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

B

JOHNSON & JOHNSON (JNJ) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering JNJ.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-21 10 $215 $175 $191.111 $156.88 21.82%
2021-12-15 10 $215 $175 $190.555 $156.88 21.47%
2022-01-26 9 $215 $175 $189.222 $156.88 20.62%
2022-01-27 9 $215 $175 $190 $156.88 21.11%
2022-03-07 10 $215 $175 $189.444 $156.88 20.76%
2022-04-04 11 $215 $175 $188.8 $156.88 20.35%
2022-04-14 11 $215 $173 $188.6 $156.88 20.22%
2022-04-20 11 $215 $173 $189.6 $156.88 20.86%
2022-04-21 11 $215 $173 $191.2 $156.88 21.88%
2022-05-20 12 $215 $173 $190.272 $156.88 21.29%
2022-06-06 12 $215 $173 $189.818 $156.88 21%
2022-09-07 16 $215 $165 $186.333 $156.88 18.77%
2022-09-17 16 $215 $165 $186.266 $156.88 18.73%
2022-10-05 15 $215 $165 $186.066 $156.88 18.6%
2022-10-12 16 $215 $165 $186.066 $156.88 18.6%
2022-10-13 16 $215 $165 $186.133 $156.88 18.65%
2022-10-14 16 $215 $165 $185.666 $156.88 18.35%
2022-10-19 17 $215 $165 $185.4 $156.88 18.18%
2022-10-20 17 $215 $160.001 $184 $156.88 17.29%
2022-11-28 17 $215 $160 $184.437 $156.88 17.57%
2022-12-01 16 $215 $160 $185.6 $156.88 18.31%
2022-12-12 17 $215 $160 $185.25 $156.88 18.08%
2023-01-20 17 $215 $160 $185.687 $156.88 18.36%
2023-01-25 17 $215 $160 $185.187 $156.88 18.04%
2023-02-21 17 $215 $168 $185.937 $156.88 18.52%
2023-03-01 18 $215 $161 $184.47 $156.88 17.59%
2023-03-31 18 $215 $161 $183.588 $156.88 17.02%
2023-04-11 18 $215 $161 $183.529 $156.88 16.99%
2023-04-12 18 $215 $161 $183.687 $156.88 17.09%
2023-04-19 17 $215 $161 $183.687 $156.88 17.09%
2023-04-21 17 $215 $161 $183.312 $156.88 16.85%
2023-06-06 17 $215 $161 $182.062 $156.88 16.05%
2023-06-14 18 $215 $161 $182.062 $156.88 16.05%
2023-07-11 17 $215 $161 $182.2 $156.88 16.14%
2023-07-13 17 $215 $161 $181.571 $156.88 15.74%
2023-07-18 16 $215 $161 $181.571 $156.88 15.74%
2023-07-21 16 $215 $161 $182.461 $156.88 16.31%
2023-07-31 15 $215 $161 $183.384 $156.88 16.89%
2023-08-30 15 $215 $161 $183.615 $156.88 17.04%
2023-08-31 16 $215 $161 $182.357 $156.88 16.24%
2023-09-06 16 $215 $161 $181.866 $156.88 15.93%
2023-09-08 16 $215 $158 $180.4 $156.88 14.99%
2023-09-12 16 $215 $158 $179.866 $156.88 14.65%

The Trend in the Analyst Price Target


JNJ's average price target has moved down $6.65 over the prior 14 months.

Over the past 49 weeks, JNJ's average upside potential has been 11.49%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-28 16 215 160 184.437 177.33 4.01%
2022-12-12 17 215 160 185.250 177.84 4.17%
2023-01-31 17 215 168 185.937 163.42 13.78%
2023-04-17 17 215 161 183.687 165.67 10.88%
2023-07-13 17 215 161 181.571 158.81 14.33%

JNJ Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.06 7 1 8 0 0 16

The Trend in the Broker Recommendations


JNJ's average broker recommendation rating worsened by 0.28 over the prior 22 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, JOHNSON & JOHNSON's average analyst price target is higher than 4926.28% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, JOHNSON & JOHNSON's number of analysts covering the stock is higher than 4864.77% of them.
  • In the context of Pharmaceutical Products stocks, JOHNSON & JOHNSON's variance in analysts' estimates is lower than -699.13% of them.
  • In terms of how JOHNSON & JOHNSON fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 881.1% of that group.

In the Pharmaceutical Products industry, PFE, LLY, and ABT are the three stocks most similar to JOHNSON & JOHNSON regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding JNJ using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!